Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Frank Czerweic, MD
Otsuka Pharmaceutical Development & Commercialization, Inc.
Study Director - Vicente Torres, MD, PhD
Mayo Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado
Denver, Colorado, United States
- Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Univerisity of Kansas Medical Center
Kansas City, Kansas, United States
- Johns Hopkins School of Medicine
Baltimore, Maryland, United States
- Davita Clinical Research
Minneapolis, Minnesota, United States
- Mayo Medical Center
Rochester, Minnesota, United States
- Rogosin Institute
New York, New York, United States
- Northwest Renal Clinic
Portland, Oregon, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Nephrology Clinical Research Center at the University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2005
- Primary completion
- 30 Jun 2010
- Completion
- 30 Jun 2010
- Last update posted
- 2 Jul 2017
- Registered enrollment
- 46
- Registry id
- NCT00413777
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.